Brief: Microbot Medical’S Novel LIBERTY Robotic System Continues To Be Validated With Latest U.S. Design Patent Allowance
18/11/2022 14:02
Nov 18 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL’S NOVEL LIBERTY® ROBOTIC SYSTEM CONTINUES
TO BE
VALIDATED WITH LATEST U.S. DESIGN PATENT ALLOWANCE
Source text for Eikon: ID:nGNX3v6KjB
Further company coverage: MBOT.O
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones